ConductScience.org, home

Paper11114375

Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.

Kumanogoh A and 15 others. Immunity, 2000. Cited by 299 papers, by iCite.

Cite this record

ConductScience Library. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Papers, record 11114375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11114375

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
PubMed
Journal
Immunity
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
299
iCite
Relative citation ratio, by iCite
4.65
iCite
Revised in PubMed
2022-03-10
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumanogoh AA
2Watanabe CC
3Lee II
4Wang XX
5Shi WW
6Araki HH
7Hirata HH
8Iwahori KK
9Uchida JJ
10Yasui TT
11Matsumoto MM
12Yoshida KK
13Yakura HH
14Pan CC
15Parnes JRJ R
16Kikutani HH

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Antigens, Differentiation, B-LymphocyteMajor topic
B-LymphocytesMajor topic
Membrane GlycoproteinsMajor topic
Receptors, ImmunologicMajor topic
SemaphorinsMajor topic
Signal TransductionMajor topic
Animals
CHO Cells
Cricetinae

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA68675NCI NIH HHSUnited StatesR01CA068675PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by141

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 299 citations.

PMIDTitleJournalYearIn PapersSource
42774833Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression.Front Immunol2026https://conductscience.org/library/papers/42774833PubMed
42524290Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing-remitting multiple sclerosis: a case-control study.Front Neurol2026https://conductscience.org/library/papers/42524290PubMed
42367882Sequential and coordinated control of human plasma cell differentiation by IRF4 and BLIMP1 utilizing a discriminating ISRE/EICE motif lexicon.bioRxiv2026https://conductscience.org/library/papers/42367882PubMed
42317326Cell-autonomous co-stimulatory function of membrane-bound CD100 promotes activation and differentiation of HBcAg-specific CD8+ T cells.Front Immunol2026https://conductscience.org/library/papers/42317326PubMed
41998221Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia.Eur J Pediatr2026https://conductscience.org/library/papers/41998221PubMed
41664229Semaphorins: from CD8⁺ T cells to cancer immunotherapy.Biomark Res2026https://conductscience.org/library/papers/41664229PubMed
41540405Single-cell sequencing-based analysis of CD4 + T-cell and B-cell heterogeneity in patients with lupus nephritis.BMC Med Genomics2026https://conductscience.org/library/papers/41540405PubMed
40728959FCGR2A-131R Is Associated with Lupus Nephritis Rather than Non-Lupus Nephritis SLE in an Indigenous African Caribbean Population.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40728959PubMed
40362578Research Advances in the Immunomodulatory Functions of CD100/SEMA4D and Their Roles in Viral Infectious Diseases.Int J Mol Sci2025https://conductscience.org/library/papers/40362578PubMed
39391510
Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma.
Heliyon2024https://conductscience.org/library/papers/39391510PubMed
39026665Soluble CD72, is a T-cell activator probably via binding to CD6 in homeostasis and autoimmunity.Front Immunol2024https://conductscience.org/library/papers/39026665PubMed
38396409Soluble Semaphorin 4D Serum Concentrations Are Elevated in Critically Ill Patients with Liver Cirrhosis and Correlate with Aminotransferases.Diagnostics (Basel)2024https://conductscience.org/library/papers/38396409PubMed
38261512Repopulated spinal cord microglia exhibit a unique transcriptome and contribute to pain resolution.Cell Rep2024https://conductscience.org/library/papers/38261512PubMed
38097864Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity.Clin Rheumatol2024https://conductscience.org/library/papers/38097864PubMed
37794420Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis during pregnancy.Arthritis Res Ther2023https://conductscience.org/library/papers/37794420PubMed
37645659Semaphorins in immune cell function, inflammatory and infectious diseases.Curr Res Immunol2023https://conductscience.org/library/papers/37645659PubMed
37605412New Promising Routes in Peptic Ulcers: Toll-like Receptors and Semaphorins.Endocr Metab Immune Disord Drug Targets2024https://conductscience.org/library/papers/37605412PubMed
37291626Pathophysiological functions of semaphorins in the sympathetic nervous system.Inflamm Regen2023https://conductscience.org/library/papers/37291626PubMed
36231105Axon Guidance Molecules and Pain.Cells2022https://conductscience.org/library/papers/36231105PubMed
35681499CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.Cells2022https://conductscience.org/library/papers/35681499PubMed

See all 141 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD72971PubTator's text mininghttps://conductscience.org/library/genes/971NCBI Gene
NR0B28431PubTator's text mininghttps://conductscience.org/library/genes/8431NCBI Gene
PTPN65777PubTator's text mininghttps://conductscience.org/library/genes/5777NCBI Gene
SEMA4D10507PubTator's text mininghttps://conductscience.org/library/genes/10507NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11114375

GET https://conductscience.org/api/papers/v1/11114375/cited_by?page=2